Literature DB >> 31132404

Structure and subunit arrangement of Mycobacterial F1FO ATP synthase and novel features of the unique mycobacterial subunit δ.

Neelagandan Kamariah1, Roland G Huber2, Wilson Nartey1, Shashi Bhushan3, Peter J Bond4, Gerhard Grüber5.   

Abstract

In contrast to other prokaryotes, the Mycobacterial F1FO ATP synthase (α3:β3:γ:δ:ε:a:b:b':c9) is essential for growth. The mycobacterial enzyme is also unique as a result of its 111 amino acids extended δ subunit, whose gene is fused to the peripheral stalk subunit b. Recently, the crystallographic structures of the mycobacterial α3:β3:γ:ε-domain and c subunit ring were resolved. Here, we report the first purification protocol of the intact M. smegmatis F1FO ATP synthase including the F1-domain, the entire membrane-embedded FO sector, and the stator subunits b' and the fused b-δ. This enzyme purification enabled the determination of the first projected 2D- and 3D structure of the intact M. smegmatis F1FO ATP synthase by electron microscopy (EM) and single particle analysis. Expression and purification of the fused mycobacterial b-δ24-446 construct, excluding the membrane-embedded N-terminal amino acids, provided insight into its secondary structure. By combining these data with homology and ab-initio modeling techniques, a model of the mycobacterial peripheral stalk subunits b-δ and b' was generated. Superposition of the 3D M. smegmatis F-ATP synthase EM-structure, the α3:β3:γ:ε and c-ring, and the derived structural models of the peripheral stalk enabled a clear assignment of all F-ATP synthase subunits, in particular with respect to the unique mycobacterial peripheral stalk subunit b' and the elongated δ fused with subunit b. The arrangement of δ relative to the N-termini of the catalytic α3β3-headpiece and its potential as a drug target are discussed.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bioenergetics; F-ATP synthase; Mycobacteria; Subunit b; Subunit δ; Tuberculosis

Mesh:

Substances:

Year:  2019        PMID: 31132404     DOI: 10.1016/j.jsb.2019.05.008

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  5 in total

1.  Anti-Mycobacterium abscessus Activity of Tuberculosis F-ATP Synthase Inhibitor GaMF1.

Authors:  Priya Ragunathan; Thomas Dick; Gerhard Grüber
Journal:  Antimicrob Agents Chemother       Date:  2022-04-28       Impact factor: 5.191

2.  Binding properties of the anti-TB drugs bedaquiline and TBAJ-876 to a mycobacterial F-ATP synthase.

Authors:  Alexander Krah; Gerhard Grüber; Peter J Bond
Journal:  Curr Res Struct Biol       Date:  2022-09-09

Review 3.  Re-Understanding the Mechanisms of Action of the Anti-Mycobacterial Drug Bedaquiline.

Authors:  Jickky Palmae Sarathy; Gerhard Gruber; Thomas Dick
Journal:  Antibiotics (Basel)       Date:  2019-12-11

4.  TBAJ-876 Displays Bedaquiline-Like Mycobactericidal Potency without Retaining the Parental Drug's Uncoupler Activity.

Authors:  Jickky Palmae Sarathy; Priya Ragunathan; Christopher B Cooper; Anna M Upton; Gerhard Grüber; Thomas Dick
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

5.  Dual inhibition of the terminal oxidases eradicates antibiotic-tolerant Mycobacterium tuberculosis.

Authors:  Bei Shi Lee; Kiel Hards; Curtis A Engelhart; Erik J Hasenoehrl; Nitin P Kalia; Jared S Mackenzie; Ekaterina Sviriaeva; Shi Min Sherilyn Chong; Malathy Sony S Manimekalai; Vanessa H Koh; John Chan; Jiayong Xu; Sylvie Alonso; Marvin J Miller; Adrie J C Steyn; Gerhard Grüber; Dirk Schnappinger; Michael Berney; Gregory M Cook; Garrett C Moraski; Kevin Pethe
Journal:  EMBO Mol Med       Date:  2020-12-07       Impact factor: 14.260

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.